Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Liekens

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|June 2, 2009
Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymesSandra Liekens, Annelies Bronckaers, Jan Balzarini
Reviews in Medical Virology|November 29, 2014
Endothelial dysfunction in dengue virus pathologyPeter Vervaeke, Kurt Vermeire, Sandra Liekens
Biochemical and Biophysical Research Communications|August 1, 2006
Stromal cell-derived factor 1 (CXCL12) binds to endothelial cells and signals through a receptor different from CXCR4Sigrid Hatse, Jan Balzarini, Sandra Liekens
Antiviral Chemistry & Chemotherapy|December 21, 2011
Angiogenic activity of hepatitis B and C virusesKristof Vrancken, Jan Paeshuyse, Sandra Liekens
Biochemical Pharmacology|June 17, 2008
The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapyAnnelies Bronckaers, Jan Balzarini, Sandra Liekens
Molecular Pharmacology|September 27, 2013
Mycoplasma hyorhinis-encoded purine nucleoside phosphorylase: kinetic properties and its effect on the cytostatic potential of purine-based anticancer drugsJohan Vande Voorde, Sandra Liekens, Jan Balzarini
EXCLI Journal|September 30, 2015
Mycoplasmas and cancer: focus on nucleoside metabolismJohan Vande Voorde, Jan Balzarini, Sandra Liekens
The Journal of Antimicrobial Chemotherapy|June 14, 2014
An emerging understanding of the Janus face of the human microbiome: enhancement versus impairment of cancer therapyJohan Vande Voorde, Jan Balzarini, Sandra Liekens
Medicinal Research Reviews|May 13, 2009
The dual role of thymidine phosphorylase in cancer development and chemotherapyAnnelies Bronckaers, Federico Gago, Jan Balzarini, et al.
Molecules (Basel, Switzerland)|July 9, 2020
Synthesis and Biological Evaluation of Analogs of Didehydroepiandrosterone as Potential New Anticancer AgentsEirik J Solum, Sandra Liekens, Trond Vidar Hansen
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|June 2, 2009
Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymesSandra Liekens, Annelies Bronckaers, Jan Balzarini
Reviews in Medical Virology|November 29, 2014
Endothelial dysfunction in dengue virus pathologyPeter Vervaeke, Kurt Vermeire, Sandra Liekens
Biochemical and Biophysical Research Communications|August 1, 2006
Stromal cell-derived factor 1 (CXCL12) binds to endothelial cells and signals through a receptor different from CXCR4Sigrid Hatse, Jan Balzarini, Sandra Liekens
Antiviral Chemistry & Chemotherapy|December 21, 2011
Angiogenic activity of hepatitis B and C virusesKristof Vrancken, Jan Paeshuyse, Sandra Liekens
Biochemical Pharmacology|June 17, 2008
The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapyAnnelies Bronckaers, Jan Balzarini, Sandra Liekens
Molecular Pharmacology|September 27, 2013
Mycoplasma hyorhinis-encoded purine nucleoside phosphorylase: kinetic properties and its effect on the cytostatic potential of purine-based anticancer drugsJohan Vande Voorde, Sandra Liekens, Jan Balzarini
EXCLI Journal|September 30, 2015
Mycoplasmas and cancer: focus on nucleoside metabolismJohan Vande Voorde, Jan Balzarini, Sandra Liekens
The Journal of Antimicrobial Chemotherapy|June 14, 2014
An emerging understanding of the Janus face of the human microbiome: enhancement versus impairment of cancer therapyJohan Vande Voorde, Jan Balzarini, Sandra Liekens
Medicinal Research Reviews|May 13, 2009
The dual role of thymidine phosphorylase in cancer development and chemotherapyAnnelies Bronckaers, Federico Gago, Jan Balzarini, et al.
Molecules (Basel, Switzerland)|July 9, 2020
Synthesis and Biological Evaluation of Analogs of Didehydroepiandrosterone as Potential New Anticancer AgentsEirik J Solum, Sandra Liekens, Trond Vidar Hansen
Pageof 12